Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17295293

Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2007 Mar 15
First author
Boccardo F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Boccardo F
      type
      Author
    2. name
      Rubagotti A
      type
      Author
    3. name
      Aldrighetti D
      type
      Author
    4. name
      Buzzi F
      type
      Author
    5. name
      Cruciani G
      type
      Author
    6. name
      Farris A
      type
      Author
    7. name
      Mustacchi G
      type
      Author
    8. name
      Porpiglia M
      type
      Author
    9. name
      Schieppati G
      type
      Author
    10. name
      Sismondi P
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Boccardo F
      type
      Author
    2. name
      Rubagotti A
      type
      Author
    3. name
      Aldrighetti D
      type
      Author
    4. name
      Buzzi F
      type
      Author
    5. name
      Cruciani G
      type
      Author
    6. name
      Farris A
      type
      Author
    7. name
      Mustacchi G
      type
      Author
    8. name
      Porpiglia M
      type
      Author
    9. name
      Schieppati G
      type
      Author
    10. name
      Sismondi P
      type
      Author
    bibliography ids
    1. nci-bib-dc232913502b97cdd55d4104
    book metadata
    content sha256
    964d49b6740712077a90068b9e4a3c5b53e8e43ac8fc30c51523d50b212c647f
    document type
    citation
    dois
    1. 10.1002/cncr.22513
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:17295293
    immutable id
    pubmed:17295293@964d49b6740712077a90068b9e4a3c5b53e8e43ac8fc30c51523d50b212c647f
    journal
    abbreviation
    Cancer
    issn electronic
    Source null
    issn print
    0008-543X
    issue
    6
    name
    Cancer
    nlm unique id
    0374236
    pages
    1060-7
    volume
    109
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      17295293
      provenance
      batch id
      e687ecc838c318f9ec65
      provider
      NCBI PubMed ESummary
      record sha256
      c62731b9821793008b1049e4dc57c0d4caf363a8b1df1b37adbc606e3f8798fb
      response sha256
      57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
      retrieved at
      2026-09-09T23:46:11.674833+00:00
      publication date
      display
      2007 Mar 15
      precision
      day
      year
      2007
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/17295293/
      title
      Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials.

      Preserved source evidence · Not medical advice